Support PenkeTaysha Gene Therapies Inc - Trending symbols
Latest News of Taysha Gene Therapies Inc
| Date | Title | Read |
|---|---|---|
| 2025-07-11 13:25 | BofA Securities initiates coverage on Taysha Gene Therapies stock with Buy rating | Read |
| 2025-07-03 19:05 | Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Read |
| 2025-06-14 12:32 | Taysha Gene Therapies' SWOT analysis: promising Rett syndrome therapy boosts stock outlook | Read |
Trends
| 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 269 | 102 | 371 | 3 | 374 | 773 | 1,147 | -1,255 | -108 | |
| Income before Tax | -55,723 | 38,101 | -17,622 | -6,976 | -24,598 | -92,489 | -117,087 | 164,828 | 47,741 | |
| Net Income | -58,057 | 37,998 | -20,059 | -4,539 | -24,598 | -92,489 | -117,087 | 164,828 | 47,741 | |
| Net Interest Income | -597 | -458 | -1,055 | -162 | -1,217 | 855 | -362 | 1,570 | 1,208 | |
| Net Income from Continuing Operations | -55,723 | 38,101 | -17,622 | -6,976 | -24,598 | -92,489 | -117,087 | 164,828 | 47,741 | |
| Net Working Capital | 9,863 | 23,764 | 33,627 | -15,724 | 17,903 | -14,429 | 3,474 | -12,118 | -8,644 | |
| Net Invested Capital | 48,899 | -9,983 | 38,916 | -15,703 | 23,213 | -21,973 | 1,240 | -11,806 | -10,566 | |
| Income Tax Expense | 1,233 | 1,101 | 2,334 | 103 | 2,437 | -994 | 1,443 | -1,774 | -331 | |
| Interest Expense | 1,241 | -445 | 796 | 578 | 1,374 | 66 | 1,440 | -2,911 | -1,471 | |
| Total Stockholder Equity | 50,725 | -18,015 | 32,710 | -21,584 | 11,126 | -10,177 | 949 | -15,897 | -14,948 |
Comments
How you think about this?